- Home
- WOK vs IMRX Comparison
WOK vs IMRX Comparison
Compare WOK & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOK
- IMRX
- Stock Information
- Founded
- WOK 2002
- IMRX 2008
- Country
- WOK China
- IMRX United States
- Employees
- WOK N/A
- IMRX N/A
- Industry
- WOK
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- WOK
- IMRX Health Care
- Exchange
- WOK NYSE
- IMRX Nasdaq
- Market Cap
- WOK 70.3M
- IMRX 64.3M
- IPO Year
- WOK 2024
- IMRX 2021
- Fundamental
- Price
- WOK $4.44
- IMRX $1.95
- Analyst Decision
- WOK
- IMRX Buy
- Analyst Count
- WOK 0
- IMRX 7
- Target Price
- WOK N/A
- IMRX $12.80
- AVG Volume (30 Days)
- WOK 268.3K
- IMRX 4.9M
- Earning Date
- WOK 02-03-2025
- IMRX 02-28-2025
- Dividend Yield
- WOK N/A
- IMRX N/A
- EPS Growth
- WOK N/A
- IMRX N/A
- EPS
- WOK N/A
- IMRX N/A
- Revenue
- WOK $9,863,642.00
- IMRX N/A
- Revenue This Year
- WOK N/A
- IMRX N/A
- Revenue Next Year
- WOK N/A
- IMRX N/A
- P/E Ratio
- WOK N/A
- IMRX N/A
- Revenue Growth
- WOK N/A
- IMRX N/A
- 52 Week Low
- WOK $3.26
- IMRX $1.00
- 52 Week High
- WOK $8.45
- IMRX $7.68
- Technical
- Relative Strength Index (RSI)
- WOK N/A
- IMRX 44.14
- Support Level
- WOK N/A
- IMRX $1.90
- Resistance Level
- WOK N/A
- IMRX $3.80
- Average True Range (ATR)
- WOK 0.00
- IMRX 0.29
- MACD
- WOK 0.00
- IMRX -0.03
- Stochastic Oscillator
- WOK 0.00
- IMRX 2.63
About WOK WORK MEDICAL TECHNOLOGY GROUP LTD
WORK Medical Technology Group Ltd is a manufacturer of medical devices, and it is committed to providing professional and reliable medical devices to the world.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.